Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668 - Wikidata - awgldk - TriplyDB

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

http://www.wikidata.org/entity/Q34701702

about

PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms Computational methods in drug discovery Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)Phase 0 trials: expediting the development of chemoprevention agents.The BATTLE to personalize lung cancer prevention through reverse migration.The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition.Early-phase development of cancer prevention agents: challenges and opportunities Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.Phase zero trials: a novel approach in drug development process.The Akt pathway in oncology therapy and beyond (Review)

P2860

Q26862544-040FC0CF-6411-4EE3-87C6-5276DB7E6D4F Q26997089-7F9B98DE-E5FE-4BE1-84FA-B723888C0F4B Q28080599-5F25DB13-12EB-4CEC-B632-B6628B692116 Q34802510-2F0251CB-AAAF-47B3-8B1F-023E05C22960 Q35208501-6D191D8A-2423-4409-8089-9974F0FB6A59 Q35884130-30847014-AFAF-4CE6-98BE-699D556FEEDD Q36853927-531A9266-E7DD-41E8-8D2B-E5207230DB4B Q36931001-771AF4A3-3D8A-4631-A9C8-10D6BE171338 Q38119561-B57165E2-F08A-4905-9186-45A08C1A0C97 Q58555910-D62F74C0-BF70-4B65-A345-1380E01C5219

P2860

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

http://www.wikidata.org/entity/Q34701702

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@ast

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@en

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@nl

type

label

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@ast

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@en

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@nl

prefLabel

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@ast

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@en

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@nl

P1433

Q34701702-8C39066A-B492-41B3-903E-DA3BE9AB546E

P1476

Q34701702-65DFEE57-E696-4ED7-9148-59AAEE65BFEA

P2093

Q34701702-17820FCA-1371-4428-AA43-0C9449A0B904

Q34701702-2E2B5E25-1DED-4515-8985-84368CB2ABEF

Q34701702-43CC79E0-80E8-422E-819F-2DE636670425

Q34701702-4B9582CB-CC70-4ED7-851C-00566BCAE35B

Q34701702-4D77856C-59B6-4AC3-9C5D-981148930E41

Q34701702-5BA35AB9-D8A3-405F-95BB-8CD414A0BDD1

Q34701702-607A77F4-C4FD-4B40-BEB9-7E689D6A0187

Q34701702-65461562-6B24-4FD3-B5CC-027292BE632A

Q34701702-6E5E8864-864D-4817-9FB3-303903A738A6

Q34701702-6E8D2276-3E43-436D-8BA7-FE8047263A50

P2860

Q34701702-05A2911A-8255-40C3-83E6-C6D46F69AF87

Q34701702-0CA177A7-266E-497D-B6AE-180A2A9F8722

Q34701702-11F84E70-FAFE-4E05-B56E-94F2E1519A74

Q34701702-27CAFB17-EC8E-4809-925E-F9AF0268EEA7

Q34701702-2A4D9EBF-94B5-4AAB-A6AC-7A0EB37A10D3

Q34701702-2E3A05EC-EEAE-4A80-BD0C-84D744B2138D

Q34701702-41BA4135-5418-43F5-89EB-03C87FBDF86F

Q34701702-4A9D45FB-9FFC-4A37-9114-DB44D9BBFAFE

Q34701702-55A0F195-C537-44C7-B38C-00D0E63A02FB

Q34701702-619E0FC0-1F49-466C-9728-50DBBF977741

P304

Q34701702-59006F13-1A6F-4E1B-B67A-996C83BA2DE4

P31

Q34701702-7215101F-C55F-4274-A91C-E3C1EC0FFD94

P356

Q34701702-AF670561-B248-4B17-ADA3-476745B8A9EC

P433

Q34701702-9011281C-78FB-4056-8897-F0CF79C47621

P478

Q34701702-D3F53881-4D7A-4E43-84B9-094F301FFD97

P577

Q34701702-18674E1C-C871-4BDD-8D9A-A288373723AE

P698

Q34701702-E46D4C3F-73C0-4FB8-BD55-939986103E09

P932

Q34701702-A391A0E7-61D6-4FEE-A5B3-A32B37B722B6

P356

1940-6207.CAPR-10-0313

P1433

Cancer Prevention Research

P1476

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

@en

P2093

Brent A Bauer

http://www.w3.org/2001/XMLSchema#string

Cancer Prevention Network

http://www.w3.org/2001/XMLSchema#string

Chad A Walden

http://www.w3.org/2001/XMLSchema#string

Cindy L Fitting

http://www.w3.org/2001/XMLSchema#string

Daniel Boring

http://www.w3.org/2001/XMLSchema#string

Eva Szabo

http://www.w3.org/2001/XMLSchema#string

James Crowell

http://www.w3.org/2001/XMLSchema#string

Joel M Reid

http://www.w3.org/2001/XMLSchema#string

John L Haslam

http://www.w3.org/2001/XMLSchema#string

Katie L Allen Ziegler

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.

Designing phase 0 cancer clinical trials.

Enhancing intestinal drug solubilisation using lipid-based delivery systems.

Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.

The statistics of phase 0 trials.

Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.

Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys.

P304

347-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-10-0313

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21372034

http://www.w3.org/2001/XMLSchema#string

P932

3061470

http://www.w3.org/2001/XMLSchema#string